Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

Published:2006-11-10 Issue:1 Volume:6 Page:
ISSN:1471-230X
Container-title:BMC Gastroenterology
language:en
Short-container-title:BMC Gastroenterol

Author:

Poynard Thierry, ,Ratziu Vlad,Charlotte Frederic,Messous Djamila,Munteanu Mona,Imbert-Bismut Françoise,Massard Julien,Bonyhay Luninita,Tahiri Mohamed,Thabut Dominique,Cadranel Jean François,Le Bail Brigitte,de Ledinghen Victor

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/article/10.1186/1471-230X-6-34/fulltext.html

Reference49 articles.

1. Sanyal AJ: AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002, 123: 1705-25. 10.1053/gast.2002.36572.

2. Angulo P: Nonalcoholic fatty liver disease. N Engl J Med. 2002, 346: 1221-31. 10.1056/NEJMra011775.

3. Charlton M: Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol. 2004, 2: 1048-58. 10.1016/S1542-3565(04)00440-9.

4. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M, Rizzetto M: Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002, 123: 134-140. 10.1053/gast.2002.34168.

5. Ratziu V, Bonyhay L, Di Martino V, Charlotte F, Cavallaro L, Sayegh-Tainturier MH, Giral P, Grimaldi A, Opolon P, Poynard T: Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology. 2002, 35: 1485-93. 10.1053/jhep.2002.33324.

Cited by 261 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noninvasive testing in the diagnosis of metabolic dysfunction-associated steatohepatitis;Metabolism and Target Organ Damage;2024-08-22

2. Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD;Current Obesity Reports;2024-05-29

3. A machine learning-based model analysis for serum markers of liver fibrosis in chronic hepatitis B patients;Scientific Reports;2024-05-27

4. Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment;Heliyon;2024-04

5. Nonalcoholic fatty liver disease: What comes before and what are the consequences?;Chronic Complications of Diabetes Mellitus;2024